Marks, Daniel J.B.
GlaxoSmithKline plc.,
United Kingdom
2024 Rank: 417676
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5673 out of 333256 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 417676 | 444140 |
| Total Cites | 1778 | 1921 |
| H-index | 17 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 44 | 44 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 923 | 988 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 975 | 1042 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1533 | 1594 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
7.44%
|
|
Marks, Daniel J.B.
GlaxoSmithKline plc.,
United Kingdom
2023 Rank: 397594
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5469 out of 321279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 397594 | 430272 |
| Total Cites | 1738 | 1882 |
| H-index | 17 | 18 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 43 | 43 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 924 | 994 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 972 | 1043 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1497 | 1560 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
7.65%
|
|
Marks, Daniel J.B.
UCL Division of Medicine,
United Kingdom
2022 Rank: 385973
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 5357 out of 311132 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 385973 | 422623 |
| Total Cites | 1620 | 1755 |
| H-index | 17 | 18 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 861 | 928 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 903 | 971 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1385 | 1443 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
7.69%
|
|
Marks, Daniel J.B.
GlaxoSmithKline plc.,
United Kingdom
2021 Rank: 390162
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Gastroenterology & Hepatology
Rank in SubField 1: 4441 out of 224174 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 390162 | 427166 |
| Total Cites | 1525 | 1656 |
| H-index | 16 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 796 | 861 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 836 | 902 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1303 | 1358 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
7.91%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.